For the study, published in the Journal of General Internal Medicine, researchers identified 134 drugs approved by the FDA before 2016 that were not endorsed by health agencies in Australia, Canada and the U.K. The three nations have health technology assessments that determine whether drugs should be covered based on effectiveness and cost.
The researchers found that Medicare covered most of the drugs that were not recommended for coverage in other countries. In particular, Medicare covered 83 percent of the medicines not recommended in Australia; 95 percent of the drugs not recommended in Canada; and 79 percent of the drugs not recommended in the U.K.
The findings on Medicare spending come as lawmakers attempt to rein in rising prescription drug costs in the U.S.
More articles on pharmacy:
9 recent drug, device recalls
Owens Healthcare to sell 12 retail pharmacies to CVS
The pharmacies that received the most opioids in every state
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
